Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -144.71% is 59% below its 1-year average of -91.00%, near the low end of its 1-year range (-144.71%–0.00%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -132.74%.
OPERATING MARGIN
-144.71%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 604 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Mobia Medical, Inc. Common Stock
Market Cap
$308.05M
Operating Margin
-144.71%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$301.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6360.33%
5Y Avg
-12157.15%
Market Cap
$317.27M
Operating Margin
-188.25%
TTM Avg
-178.83%
3Y Avg
-158.00%
5Y Avg
-158.00%
Market Cap
$321.20M
Operating Margin
-290.68%
TTM Avg
-313.41%
3Y Avg
-428.31%
5Y Avg
-345.79%
Market Cap
$322.03M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$291.99M
Operating Margin
-109.34%
TTM Avg
-104.90%
3Y Avg
-100.12%
5Y Avg
-81.51%
Market Cap
$286.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$286.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$333.14M
Operating Margin
-18.00%
TTM Avg
-67.22%
3Y Avg
-104.89%
5Y Avg
-90.63%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $308.05M | -144.71% | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $301.88M | 0.00% | 0.00% | -6360.33% | -12157.15% |
| CapsoVision, Inc. (CV)vs › | $317.27M | -188.25% | -178.83% | -158.00% | -158.00% |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.20M | -290.68% | -313.41% | -428.31% | -345.79% |
| Cabaletta Bio, Inc. (CABA)vs › | $322.03M | 0.00% | 0.00% | 0.00% | 0.00% |
| Standard BioTools Inc. (LAB)vs › | $291.99M | -109.34% | -104.90% | -100.12% | -81.51% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $286.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $286.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Agenus Inc. (AGEN)vs › | $333.14M | -18.00% | -67.22% | -104.89% | -90.63% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $333.18M | -65.36% | -64.13% | -75.36% | -72.00% |
Gross Margin
81.1%
Operating Margin
-144.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -132.74% |
| 2026-03-31 | -140.28% |
| 2025-12-31 | 0.00% |
